A.R.T. Advisors’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

A.R.T. Advisors’s Portfolio BCLI Stock Details BCLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell
2017 Q4	$65K	Buy
2017 Q3	$49K	Buy
2016 Q2	–	Sell
2016 Q1	$60K	Sell
2015 Q4	$86K	Buy